Moreover, BPA combined with insulin favors the conversion of fibroblasts to adipocytes (Masuno et al. 2002), enhancing the risk of obesity, a metabolic disorder that has been related to endocrine disruptors in the last years (Heindel 2003; Mead 2004). The gene discussed is INS; the disease is obesity disorder.